CLINICAL_TRIALS
trial_result
· 2023-06-18
Clinical Trial Update: Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer [Phase 2]
Summary
Phase 2 clinical trial evaluating paclitaxel and carboplatin for locally advanced or metastatic kidney cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eastern Cooperative Oncology Group | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED